US FDA declines to approve Milestone's heart rhythm nasal spray
Milestone Pharmaceuticals said on Friday that the U.S. health regulator had declined to approve its nasal spray to treat a ...
Endpoints News12h
Mile­stone's shares dive af­ter FDA again re­jects drug for ab­nor­mal heart rhythm
Milestone Pharmaceuticals' nasal spray etripamil fails FDA approval for PSVT due to CMC issues, sending shares down 60%. Drug's efficacy and safety weren't questioned.
Pitching in: Improving treatment for abnormal heart rhythm
Greg Wolfe purchased a $200,000 Medtronic PulseSelect machine for Vancouver General Hospital, which the hospital has used for more than 200 procedures ...
Mitrovic misses training over abnormal heart rhythm
Former Newcastle United and Fulham forward Aleksandar Mitrovic misses training with Al-Hilal because of an abnormal heart rhythm.
PharmiWeb17h
Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...
Abbott gets CE mark for Volt pulsed field ablation system to treat patients with abnormal heart rhythms
Thursday announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib).